Barriers to monitoring and management of cardiovascular and metabolic health of patients prescribed antipsychotic drugs: a systematic review
Abstract Background The use of atypical antipsychotics which currently form the primary choice pharmacotherapy for several mental health conditions have been linked to cardiovascular and metabolic side effects. This systematic review aimed to investigate the barriers to monitoring and management of...
Main Authors: | Ruba Azfr Ali, Zahraa Jalal, Vibhu Paudyal |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12888-020-02990-6 |
Similar Items
-
Cardiometabolic screening and monitoring in patients prescribed antipsychotic drugs in primary care: A population-based cohort study
by: Ruba Azfr Ali, et al.
Published: (2023-11-01) -
Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand?
by: Zahraa Jalal, et al.
Published: (2021-08-01) -
Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
by: Ye Yang, et al.
Published: (2022-03-01) -
Identification of Antipsychotic Side Effects with Glassgow Antipsychotic Side-Effect Scale (GASS)
by: Dita Hasni, et al.
Published: (2020-08-01) -
Adverse health events associated with antipsychotic use: an umbrella review
by: Chow, RTS
Published: (2021)